Frozen tumor sections and/or cytological smears and aspirates from 614 pateints were studied utilizing the fluorescent estrogen binding technique of Lee. Survival analyses of the results indicated that women less than 55 years of age and with positive tumors had a statistically better disease-free interval and survived significantly longer than older patients. The method is thus an independent predictor of survival and disease-free interval in this siubgroup of breast cancer patients.
KinneD.W., ButlerA., Menendez-BotetC., RosenP.P., SchwartzM.Estrogen receptor protein in breast cancer as a predictor of recurrence.Cancer1981; 47: 2364–7.
2.
AamdalS., BormerO., JorgensenO.. Estrogen receptors and long-term prognosis in breast cancer.Cancer1984; 53: 2525–9.
3.
PariF.F., SchmidtB.P., DupontW.D., WagnerR.K.Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axilary node metastasis, and histopathologic grading.Cancer1984; 54: 2237–42.
4.
HowatJ.M.T., HarrisM., SwindellR., BarnesD.M.The effect of estrogen and progesterone receptor on recurrence and survival in patiens with carcinoma of the breast.Br J Cancer1985; 51: 263–70.
5.
LeeS.H.Cytochemical study of estrogen receptor in human mammary cancer.Am J Pathol1978; 70: 197–203.
6.
LeeS.H.Cellular estrogen and progesterone receptors in mammary carcinoma.Am J Pathol1980; 73: 319–23.
7.
Determination of hormone receptors in breast tumors by histochemical methods.Round Table. Istocitopa-tologia1984; 6: 3–88.
YaoX., LeeS.H., TourvilleD.R.A histochemical technique for the demonstration of estrogen receptor in human breast cancer.Istocitopatologia1984; 6: 5–9.
10.
ReguzzoniG., StagniF., LamperticoP.Risultati preliminari della correlazione clinica fra assetto recettoriale e follow-up.Istocitopatologia1984; 6: 73–8.
11.
De GiuliP., GubettaL.Follow-up di pazienti con assetto recettoriale determinato con metodo radiometrico e istochimico.Pathologica1985; 77: 311–314.
12.
GhislandiE., GottardiO.Correlazione fra assetto recettoriale istologicamente determinato e decorso clinico nei tumori della mammella.Pathologica1985; 77: 323–35.
13.
ReguzzoniG., SchieppatiG., StagniF., LamperticoP.Correlazioni cliniche preliminari con l'assetto recettoriale determinato con metodo istochimico sui tumori mammari primitivi e su lesioni secondarie.Pathologica1985; 77: 337–46.
14.
ChenP., YaoX., MeiZ., MengX.Histochemical sex hormone receptor assay and treatment of breast cancer in Chinese patients. In: PertschukL.P., LeeSH.Localization of putative steroid receptors. Vol. II Clinically Oriented Studies, CRC Press Inc., Boca Raton, Fl.1985; 52–62.
15.
LamperticoP., StagniF.Cancer of the breast. Clinico-pathological correlations in primary, recurrent, and metastatic tumors with histochemically determined hormone receptors. In: PertschukL.P., LeeSH.Localization of putative steroid receptors. Vol. II, Clinically Oriented Studies, CRC Press Inc, Boca Raton, Fl.1985; 63–84.
16.
HannaW., PrichardK.I.How to validate histochemical techniques as predictor of hormonal response. In: PertschukL.P., LeeSH.Localization of putative steroid receptors. Vol. II, Clinically Oriented Studies, CRC Press Inc.Boca Raton, Fl.1985; 85–92.
17.
PetoR., PikeM., SmithP.G.. Design and analysis of randomized cclinical trials requiring prolonged observation of each patient. Part II: Agn and analysis of randomized clinical trials requiring prolonged observation of each patient. Part II: Analysis.Br J Cancer1977; 35: 1–39.
18.
McCartyK.S., IngramD.L.Jr., McCartyK.S.Sr.. Critical issue in the evaluation of histochemical and biochemical methods for steroid receptor analysis. In: PertschukL.P., LeeSH.Localization of putative steroid receptors. Vol II Clinically Oriented Studies, CRC Press Inc, Boca Raton, Fl.1985; 149–64.
19.
FeldmanJ.G., PertschukL.P., CarterA.C.Eisenberg KB, Fleisher J. Histochemical estrogen binding: an independent predictor of recurrence and survival in Stage II breast cancer.Cancer1986; 57: 911–6.
20.
UnderwoodJ.C.E.Oestrogen receptors in human breast cancer: Review of hisotpathological correlations and critique of histochemical methods.Diagnostic Histopathology1983; 6: 1–22.
21.
SismondiP., BarengoR., BottaR.. Prognostic values of estrogen receptors (ER) and progesterone receptors (PgR) as determined by radiochemical and histochemical methods in breast cancer a multicentric experience.Breast Caner Res Treat1982; 2: 279.
22.
JanssensJ.P., PylyserK., BekaertJ.. Biochemical and histochemical analysis of steroid hormone binding sites in human primary breast cancer.Cancer1985; 55: 2600–11.
23.
MeijerCJLM, Van MarieJ., Van NiewenhuizenW., BaakJ.P.A., BoonM.E., LindemanJ.Estrogen receptors in human breast cancer. II Correlation between the histochemical method and biochemical assay. Wir-chows Arch.(Cell Pathol)1982; 40: 27–36.
24.
WolfD., FortiE., GionM., MeliaM., DittadiR., MioneR.Determinazione dei recettori citoplasmatici di estrogeni e progesterone nel carcinoma mammario: confronto tra un metodo istochimico e un metodo radiometrico.Pathologica1985; 77: 305–9.
25.
MenisM., TosoC., RoccoM., PizzolitoS., AntociB.Confronto e correlazioni deirisultati ottenuti per la ricerca dei recettori steroidei con il metodo istochimico fluorescente e radiometrico su 300 casi di carcinoma mammario.Pathologica1985; 77: 299–303.
26.
FurnivalC.M., ChongK.C., WastsonL.R., VisonaA.Fluorescent cytochemical oestrogen receptor assay: is it valid breast cancer?Br J Surg1983; 70: 457–9.
27.
MasoodS., JohnsonH.The value of imprint cytology in cytochemical detection of steroid hormone receptors in breast cancer.Am J Clin Pathol1987; 87: 30–6.
28.
Vollenweider-ZerarguiL., BarreletL., WongY., Le-marchang-BeraudT., GomezF.The predictive value of estrogen and progesterone receptors’ concentrations on the clinical behavior of breast cancer in women.Cancer1986; 57: 1171–80.
29.
PertschukL.P., EisenbergK.G., CarterA.C., FeldmanJ.G.Morfologic detection of multiple steroid binding sites in breast cancer by histochemistry and by immu-nocytochemistry with monoclonal antireceptor antibody: relationship to endocrine response. In: PertschukL.P., LeeSH.Localization of putative steroid recpetors. Vol II Clinically Oriented Studies, CRC Press Inc, Boca Raton, F1.1985; 15–36.
30.
LamperticoP., StagniF.Correlazioni tra assetto recettoriale e vari parametri clinicomorfologici: valutazioni su circa 2000 casi di tumori mammari.Pathologica1985; 77: 281–97.
31.
TunesiG., AnselmiL., BandelloniR., GambiniC., RealeA., SementaA.R., BronziniE.Parametri morfologici e morfometrici di carcinomi duttali infiltranti della mammella e assetto recettoriale in fluorescenza.Pathologica1985; 77: 251–8.
32.
LamperticoP., StagniF.Cytology and hormonal receptors in breast cancer.Diagn Cytopathol1987; 3: 17–23.
33.
TaylorC.R., CooperC.L., KurmmaR.Y., GoebelsmannU., MarklandF.S.Detection of estrogen receptor in breast and endometrial carcinoma by immunoperoxi-dase technique.Cancer1981; 47: 2634–40.
34.
KingW.J., GreeneG.L.Monoclonal antibodies localize estrogen receptor in the nuclei of target cells.Nature1984; 307: 745–7.
35.
LamperticoP., StagniF., CrosignaniP.Applicazione di metodiche multiple per la determinazione dell'assetto recettoriale nei tumori mammari.Pathologica1987; 79: 83–90.
36.
CanoA., CofferA., AdatiaR., MillisR., RubensR., KingR.Histochemical studies with an oestrogen receptor protein in human breast tumors.Cancer Res1986; 46: 6475–80.
37.
BussolatiG., PietribiasiF., GugliottaP., ContiG., Di CarloF.Correlazione tra dati istopatologici ed immu-noistochimici (con impiego dell'anticorpo D5) ed analisi biochimica nello studio dei recettori estrogenici in carcinomi mammari.Pathologica1987; 79: 45–50.
